Journal of the American Academy of Dermatology
Publisher: Elsevier · ISSN 0190-9622 · 80 articles
- Re: Comparative and complementary diagnostic value of dermatoscopy and clinical close-up photography in skin cancer diagnosis: A study from the MILK10k dataset
- Response to Bisha et al., “Re: Comparative and complementary diagnostic value of dermatoscopy and clinical close-up photography in skin cancer diagnosis: A study from the MILK10k dataset”
- Response to Du et al, “Beyond gastrointestinal symptom burden: Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa”
- Beyond gastrointestinal symptom burden: Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa
- Response to Wang et al, “Cartilage grafts for alar reconstruction in nasolabial interpolation flap surgery may negatively affect breathing function and cosmesis: A retrospective study”
- Accredited compounding pharmacies: A complementary approach to injectable triamcinolone acetonide shortages
- Response to Smith et al, “Accredited compounding pharmacies: A complementary approach to injectable triamcinolone acetonide shortages”
- Response to the letter by Ghanim et al, “Comment on Gao et al’s ‘A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis’”
- Comment on Gao et al’s “A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis”
- Hispanic ethnicity does not influence the relationship between obesity with atopic dermatitis: Response to Letter regarding Hispanic ethnicity as a covariate
- Hispanic ethnicity as an unconsidered variable in the obesity‑atopic dermatitis relationship
- Response to Guan et al, “Letter to the Editor ‘Rethinking routine cartilage grafting for alar defects’”
- Rethinking routine cartilage grafting for alar defects
- Methodologic considerations and real-world challenges in evaluating the long-term efficacy of 5-fluorouracil for Bowen's disease: A response to Moermans et al
- Response to Zhao, “Methodologic considerations and real-world challenges in evaluating the long-term efficacy of 5-fluorouracil for Bowen disease: A response to Moermans et al”
- Considerations on the relation between Medicaid expansion and overall survival in patients with resected Merkel cell carcinoma
- Response to Fuentes and Joshi, “Considerations on the relation between Medicaid expansion and overall survival in patients with resected Merkel cell carcinoma”
- Response to Jean et al, “Alopecia after glucagon-like peptide-1 agonist therapy: A TriNetX Database active comparator retrospective cohort study”
- Methodological concerns regarding “Alopecia after GLP-1 agonist therapy: A TriNetX database active comparator retrospective cohort study”
- December 2026 iotaderma (#394)
- Response to Wu et al “Clinical Potential of Antimicrobial Photodynamic Therapy”
- Clinical potential of antimicrobial photodynamic therapy
- Correspondence to Abdel Azim et al, “Sunscreens part 2: Regulation and safety”. Regulatory gaps in sunscreen approval: A comparison of U.S. and Korean UV filters
- Response to Pak et al, “Regulatory gaps in sunscreen approval: A comparison of U.S. and Korean UV filters.” Sunscreen regulatory update: approval of bemotrizinol by the US FDA
- Response to van Rooij, “Clinical context and comparative interpretation of dermatologic disease burden in people with HIV in the modern antiretroviral era”
- Response to Akiska et al., “Prevalence, incidence, and risk factors for dermatologic conditions in people with HIV in the modern antiretroviral era: A cohort study in Washington, DC”
- Response to Guo et al, “Response to Huang et al’s ‘Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: An analysis of national multicenter data from the Chinese Rheumatism Data Center (CRDC)’”
- Response to Huang et al, “Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: An analysis of national multicenter data from the CRDC”
- Photodynamic therapy for onychomycosis: Interpreting current evidence
- Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic disease-modifying antirheumatic drugs in psoriasis and psoriatic arthritis: A 15-year multicenter cohort study